Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenichi Yamada

Showing results (51-60 of 54) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 54 results.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|April 2, 2004
Renoprotective effect of losartan in comparison to amlodipine in patients with chronic kidney disease and hypertension--a report of the Japanese Losartan Therapy Intended for the Global Renal Protection in Hypertensive Patients (JLIGHT) studyYasuhiko Iino, Matsuhiko Hayashi, Tetsuya Kawamura, et al.
Clinical and Experimental Nephrology|October 31, 2003
Interim evidence of the renoprotective effect of the angiotensin II receptor antagonist losartan versus the calcium channel blocker amlodipine in patients with chronic kidney disease and hypertension: a report of the Japanese Losartan Therapy Intended for Global Renal Protection in Hypertensive Patients (JLIGHT) StudyYasuhiko Iino, Matsuhiko Hayashi, Tetsuya Kawamura, et al.
Diabetes Technology & Therapeutics|June 14, 2013
Glucagon underutilized among type 1 diabetes mellitus patients in JapanTakashi Murata, Kentaro Okazaki, Katsuyuki Yanagisawa, et al.
Journal of Diabetes Investigation|September 30, 2015
Fear of hypoglycemia and its determinants in insulin-treated patients with type 2 diabetes mellitusNaoki Sakane, Kazuhiko Kotani, Kokoro Tsuzaki, et al.
Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 54 results.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|April 2, 2004
Renoprotective effect of losartan in comparison to amlodipine in patients with chronic kidney disease and hypertension--a report of the Japanese Losartan Therapy Intended for the Global Renal Protection in Hypertensive Patients (JLIGHT) studyYasuhiko Iino, Matsuhiko Hayashi, Tetsuya Kawamura, et al.
Clinical and Experimental Nephrology|October 31, 2003
Interim evidence of the renoprotective effect of the angiotensin II receptor antagonist losartan versus the calcium channel blocker amlodipine in patients with chronic kidney disease and hypertension: a report of the Japanese Losartan Therapy Intended for Global Renal Protection in Hypertensive Patients (JLIGHT) StudyYasuhiko Iino, Matsuhiko Hayashi, Tetsuya Kawamura, et al.
Diabetes Technology & Therapeutics|June 14, 2013
Glucagon underutilized among type 1 diabetes mellitus patients in JapanTakashi Murata, Kentaro Okazaki, Katsuyuki Yanagisawa, et al.
Journal of Diabetes Investigation|September 30, 2015
Fear of hypoglycemia and its determinants in insulin-treated patients with type 2 diabetes mellitusNaoki Sakane, Kazuhiko Kotani, Kokoro Tsuzaki, et al.
Pageof 6